시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 생분해성 임플란트 장치 시장 분석 및 예측(-2034년) : 유형, 제품, 기술, 재료 유형, 용도, 프로세스, 최종 사용자, 기능, 설치 유형
Biodegradable Implant Devices Market Analysis and Forecast to 2034: Type, Product, Technology, Material Type, Application, Process, End User, Functionality, Installation Type
상품코드 : 1699186
리서치사 : Global Insight Services
발행일 : 2025년 04월
페이지 정보 : 영문 413 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,750 ￦ 6,858,000
Single User License help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능하며, 인쇄는 가능합니다.
US $ 5,750 ￦ 8,301,000
Site License help
PDF, Excel 보고서를 동일 기업(국가)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,750 ￦ 9,745,000
Enterprise License help
PDF, Excel 보고서를 동일 기업의 전 세계 모든분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 생분해성 임플란트 장치 시장은 2024년 64억 달러에서 2034년까지 122억 달러로 확대되어 CAGR 약 6.7%를 보일 것으로 예측됩니다. 생체 적합성 재료로 만들어진 이러한 장치는 주로 정형외과, 심장혈관, 치과용도에서 사용됩니다.

시장 개요:

생분해성 임플란트 장치 시장은 지속가능한 의료 솔루션에 대한 수요 증가와 생체재료 과학의 진보로 강력한 확대를 경험하고 있습니다. 이에 대한 관심 증가로 인해 시장의 주요 부문으로 부상하고 있습니다. 심장혈관용이나 치과용 생분해성 임플란트와 같은 신흥 하위 부문은 시장 전망에 큰 영향을 미칠 것으로 보입니다. 치과 수술에서 생분해성 재료의 채용 확대로 혜택을 받아 환자의 예후 개선과 장기 합병증의 감소를 실현하고 있습니다.

시장 세분화
유형 정형외과용 임플란트, 치과용 임플란트, 심장혈관용 임플란트, 안과용 임플란트
제품 스크류, 핀, 플레이트, 스텐트, 메쉬, 스캐폴드
기술 3D 프린팅, 나노 기술, 바이오 프린팅, 표면 개질
재료 유형 폴리유산(PLA), 폴리글리콜산(PGA), 폴리카프로락톤(PCL), 폴리디옥사논(PDO)
용도 외상, 척추, 재건 외과, 치과 수복, 안과
프로세스 사출 성형, 압출 성형, 열 성형
최종 사용자 병원, 외래수술센터(ASC), 전문 클리닉, 연구 기관
기능성 내하중, 비내하중
설치 유형 내부 고정, 외부 고정

생분해성 임플란트 장치는 정형외과 분야와 심장혈관 분야가 시장을 선도하고 있습니다. 북미는 여전히 채용의 최전선에 있습니다만, 유럽과 아시아태평양은 헬스케어 투자와 기술 진보 증가에 의해 현저한 성장을 이루고 있습니다. Medtronic, Stryker, Boston Scientific과 같은 주요 기업이 지속적인 기술 혁신을 통해 제품 라인업을 강화하고 있다는 점을 들 수 있습니다. 이후 고령화 사회의 도래와 만성질환 증가로 시장은 강력한 성장을 이룰 것으로 생각되고 있습니다.

주요 동향 및 촉진요인:

생분해성 임플란트 장치 시장은 몇 가지 주요 동향과 촉진요인에 의해 강력한 성장을 이루고 있습니다. 이 변화는 신체에서 자연적으로 용해되어 추가 수술의 필요성을 줄이는 생분해성 임플란트의 개발과 채용을 촉진하고 있습니다. 만성질환의 만연과 인구의 고령화도 수요에 박차를 가하고 있습니다. 자금 제공을 통해 생분해성 의료장치의 사용을 장려하고 있습니다. 또한, 특히 신흥국에서의 헬스케어 지출 증가가 시장 성장의 기회를 가져오고 있습니다.

억제요인과 도전:

생분해성 임플란트 장치 시장은 현재 몇 가지 중요한 시장 성장 억제요인과 과제를 가지고 있습니다. 또한 규제 상황은 복잡하고 지역에 따라 크게 다르므로 세계 시장 진출을 목표로하는 제조업체에게는 장애물이 생길 수 있습니다. 데이터가 부족하다는 것은 건강 관리 전문가와 환자 사이에 우려가 있습니다. 기존의 재료의 기계적 강도와 내구성에 필적하는 생분해성 재료의 개발에 있어서의 기술적 한계가, 보급의 큰 장벽이 되고 있습니다. 이러한 과제는 총체적으로 생분해성 임플란트 장치 시장의 성장 궤도를 저해하고 있습니다.

목차

제1장 생분해성 임플란트 장치의 개요

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 생분해성 임플란트 장치의 전망

제5장 생분해성 임플란트 장치 전략

제6장 생분해성 임플란트 장치 시장 규모

제7장 생분해성 임플란트 장치 : 유형별

제8장 생분해성 임플란트 장치 : 제품별

제9장 생분해성 임플란트 장치 : 기술별

제10장 생분해성 임플란트 장치 : 재료 유형별

제11장 생분해성 임플란트 장치: 용도별

제12장 생분해성 임플란트 장치: 프로세스별

제13장 생분해성 임플란트 장치: 최종 사용자별

제14장 생분해성 임플란트 장치 : 기능별

제15장 생분해성 임플란트 장치 : 설치 유형별

제16장 생분해성 임플란트 장치 : 지역별

제17장 경쟁 구도

제18장 기업 프로파일

JHS
영문 목차

영문목차

Biodegradable Implant Devices Market is anticipated to expand from $6.4 billion in 2024 to $12.2 billion by 2034, growing at a CAGR of approximately 6.7%. The market encompasses medical implants designed to naturally decompose within the body, eliminating the need for surgical removal. These devices, made from biocompatible materials, are primarily used in orthopedics, cardiovascular, and dental applications. The market is driven by the growing preference for minimally invasive procedures, increasing geriatric population, and advancements in material science. Innovations in polymer technology and rising healthcare expenditure further bolster market growth, presenting lucrative opportunities for stakeholders.

Market Overview:

The Biodegradable Implant Devices Market is experiencing robust expansion, spurred by the escalating demand for sustainable medical solutions and advancements in biomaterial science. The orthopedic segment emerges as the leading market segment, driven by the increasing prevalence of musculoskeletal disorders and the heightened focus on patient-specific, biocompatible solutions. This segment's dominance is attributed to the technological superiority of biodegradable materials that facilitate natural bone healing processes and reduce the need for secondary surgeries. Emerging sub-segments, such as cardiovascular and dental biodegradable implants, are poised to significantly impact the market landscape. The cardiovascular sub-segment is gaining momentum due to the rising incidence of cardiovascular diseases and the need for minimally invasive treatment options. Meanwhile, the dental sub-segment benefits from the growing adoption of biodegradable materials in dental surgeries, offering improved patient outcomes and reduced long-term complications. These emerging sub-segments are expected to foster innovation and diversification within the biodegradable implant devices market.

Market Segmentation
TypeOrthopedic Implants, Dental Implants, Cardiovascular Implants, Ocular Implants
ProductScrews, Pins, Plates, Stents, Meshes, Scaffolds
Technology3D Printing, Nanotechnology, Bioprinting, Surface Modification
Material TypePolylactic Acid (PLA), Polyglycolic Acid (PGA), Polycaprolactone (PCL), Polydioxanone (PDO)
ApplicationTrauma, Spinal, Reconstructive Surgery, Dental Restoration, Ophthalmic
ProcessInjection Molding, Extrusion, Thermoforming
End UserHospitals, Ambulatory Surgical Centers, Specialty Clinics, Research Institutes
FunctionalityLoad-Bearing, Non Load-Bearing
Installation TypeInternal Fixation, External Fixation

Biodegradable implant devices dominate the market landscape, with orthopedic and cardiovascular segments leading the charge. This distribution is driven by the increasing demand for advanced medical solutions that reduce long-term complications and improve patient outcomes. North America remains at the forefront of adoption, while Europe and Asia-Pacific are witnessing significant growth due to rising healthcare investments and technological advancements. The competitive landscape is characterized by key players such as Medtronic, Stryker, and Boston Scientific, who are continuously innovating to enhance product offerings. Regulatory frameworks, particularly in the United States and Europe, are crucial in shaping market dynamics, ensuring safety and efficacy standards are met. Looking ahead, the market is poised for robust growth, fueled by the aging population and increased prevalence of chronic diseases. Challenges such as stringent regulatory approvals and high development costs persist, yet advancements in biomaterials and 3D printing technologies present substantial opportunities for market expansion.

Geographical Overview:

The biodegradable implant devices market is witnessing varied growth patterns across different regions. North America is at the forefront, driven by advanced healthcare infrastructure and increasing awareness of sustainable medical practices. The region's regulatory framework supports innovation, encouraging the adoption of biodegradable implants. Europe follows, characterized by a strong emphasis on eco-friendly medical solutions and robust research initiatives. The European market benefits from collaborative efforts between academia and industry. In Asia Pacific, the market is expanding rapidly due to rising healthcare expenditure and growing patient awareness. Countries like China and India are investing in research and development to enhance biodegradable technologies. This region's vast population base presents significant opportunities for market penetration. Latin America is emerging as a potential market, with improvements in healthcare infrastructure and increasing governmental support for sustainable medical practices. The Middle East & Africa are gradually recognizing the benefits of biodegradable implant devices. Economic diversification and healthcare advancements drive growth in these regions. Efforts to modernize healthcare systems and enhance patient outcomes are pivotal. Overall, the biodegradable implant devices market presents lucrative opportunities, with regional dynamics playing a crucial role in shaping its trajectory.

Recent Development:

The biodegradable implant devices market has witnessed notable developments in recent months, underscoring its dynamic nature. In August, Johnson & Johnson announced a strategic partnership with a leading biotech firm to enhance the production and distribution of biodegradable implants, aiming to address the growing demand for sustainable medical solutions. September saw Medtronic unveiling its latest line of biodegradable stents, designed to naturally dissolve in the body, reducing the long-term risks associated with permanent implants. In a significant regulatory update, the European Medicines Agency in early October approved a new class of biodegradable orthopedic screws, paving the way for broader adoption across Europe. Meanwhile, Stryker Corporation reported a substantial increase in its quarterly profits, attributing the growth to the rising adoption of its biodegradable implant products. Lastly, Boston Scientific expanded its manufacturing facilities in Asia to bolster the supply chain for biodegradable implants, ensuring better market penetration in the region. These developments highlight the sector's momentum towards innovation and sustainability.

Key Trends and Drivers:

The biodegradable implant devices market is experiencing robust growth, propelled by several key trends and drivers. One prominent trend is the increasing preference for eco-friendly medical solutions. As environmental concerns rise, healthcare providers and patients are seeking sustainable alternatives to traditional implants. This shift is driving the development and adoption of biodegradable implants, which naturally dissolve in the body, reducing the need for additional surgeries. Technological advancements are another crucial driver. Innovations in materials science are enabling the creation of stronger, more reliable biodegradable implants. These advancements are improving patient outcomes and broadening the scope of applications for these devices. The growing prevalence of chronic diseases and an aging population are also fueling demand. Older patients often require implants, and biodegradable options offer a safer, less invasive solution. Regulatory support is further bolstering market expansion. Governments worldwide are encouraging the use of biodegradable medical devices through favorable policies and funding for research. Additionally, the rise in healthcare expenditure, particularly in emerging economies, is providing opportunities for market growth. Companies investing in research and development to produce cost-effective, high-quality biodegradable implants are well-positioned to capture significant market share.

Restraints and Challenges:

The biodegradable implant devices market is currently navigating several significant restraints and challenges. A primary challenge is the high cost of production associated with biodegradable materials, which increases the overall cost of these devices. This financial burden can limit their adoption, particularly in emerging markets. Additionally, the regulatory landscape is complex and varies significantly across regions, posing hurdles for manufacturers seeking global market entry. The lack of long-term clinical data on the efficacy and safety of biodegradable implants also raises concerns among healthcare professionals and patients. Furthermore, there is a need for enhanced awareness and education among both medical practitioners and patients regarding the benefits and limitations of these devices. Lastly, the technological limitations in the development of biodegradable materials that can match the mechanical strength and durability of traditional materials remain a significant barrier to widespread adoption. These challenges collectively impede the growth trajectory of the biodegradable implant devices market.

Key Companies:

Stryker, Medtronic, Zimmer Biomet, Smith and Nephew, Nu Vasive, Globus Medical, KLS Martin Group, Wright Medical Group, Arthrex, Con Med Corporation, RTI Surgical, Biotronik, Integra Life Sciences, Ortho Pediatrics, Aesculap Implant Systems, Exactech, Spine Wave, Orthofix Medical, Cayenne Medical, Bioretec

Sources:

World Health Organization, U.S. Food and Drug Administration, European Medicines Agency, National Institutes of Health, World Medical Association, International Society for Medical Innovation and Technology, American Society for Biomaterials, International Conference on Biomedical Engineering and Biotechnology, International Conference on Biomaterials, Biodegradables & Biomimetics, Materials Research Society, National Institute of Standards and Technology, European Society for Biomaterials, International Union of Societies for Biomaterials Science and Engineering, International Federation of Medical and Biological Engineering, National Science Foundation, U.S. National Library of Medicine, International Conference on Biodegradable Polymers and Plastics, University College London - Division of Surgery & Interventional Science, Massachusetts Institute of Technology - Department of Materials Science and Engineering, Stanford University - Biomaterials and Advanced Drug Delivery.

Research Scope:

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Biodegradable Implant Devices Overview

2: Executive Summary

3: Premium Insights on the Market

4: Biodegradable Implant Devices Outlook

5: Biodegradable Implant Devices Strategy

6: Biodegradable Implant Devices Size

7: Biodegradable Implant Devices, by Type

8: Biodegradable Implant Devices, by Product

9: Biodegradable Implant Devices, by Technology

10: Biodegradable Implant Devices, by Material Type

11: Biodegradable Implant Devices, by Application

12: Biodegradable Implant Devices, by Process

13: Biodegradable Implant Devices, by End User

14: Biodegradable Implant Devices, by Functionality

15: Biodegradable Implant Devices, by Installation Type

16: Biodegradable Implant Devices, by Region

17: Competitive Landscape

18: Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기